Azerbaijan vs Estonia: The number of people with susceptibility test result for rifampicin
Azerbaijan
96.11
in 2021
Estonia
96.1
in 2021
Azerbaijan rank
47th
Estonia rank
48th
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Estonia
How they compare
Azerbaijan currently reports 96.11 against 96.1 in Estonia, a difference of 0.01.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Estonia ahead.
Azerbaijan ranks 47th and Estonia ranks 48th of 146 countries.
Estonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.09 | 99.41 | 0.3214 | Estonia |
| 2020s | 94.83 | 95.95 | 1.12 | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Estonia?
- Azerbaijan, at 96.11 against 96.1 in Estonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Estonia?
- 0.01, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Estonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Estonia rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 47th and Estonia ranks 48th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.